Multiple sclerosis and autoimmune diseases - Epidemiology and HLA-DR association in North-east Italy

被引:34
|
作者
Laroni, Alice
Calabrese, Massimiliano
Perini, Paola
Albergoni, Maria Paola
Ranzato, Federica
Tiberio, Michela
Battistin, Leontino
Gallo, Paolo
机构
[1] Univ Padua, Dept Neurosci, Neurol Clin 1, I-35128 Padua, Italy
[2] Univ Hosp Padova, Blood & Tissue Bank, Padua, Italy
[3] IRCCS San Camillo, Venice Lido, Italy
关键词
multiple sclerosis; autoimmune disease; epidemiology; HLA-DR;
D O I
10.1007/s00415-006-0084-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
An autoimmune background is thought to characterize the families of multiple sclerosis (MS) patients, but disease patterns and HLA-DR association seem to vary considerably among different ethnic groups. We investigated the prevalence of autoimmune diseases in 245 MS patients and 245 age- and sex-matched normal controls (NC), originating from and living in North-east Italy, and their first degree relatives, using a case-control method. Further, HLA-DRB1 expression was analysed in MS and NC. The following significant findings were observed: 1) a significant excess of autoimmunity in firstdegree relatives of MS patients (p = 0.000), 2) an association of MS with Type 1 diabetes mellitus (T1DM) (p = 0.02), 3) an increase in DR4 expression (namely DRB1*0401) in MS patients from families with multiple autoimmune pathology compared with reference MS patients (p=0.02) and NC (p=0.01).We conclude that the risk of autoimmune disease is higher in first-degree relatives of MS patients and that disease association and HLA-DR expression in North-east Italy differs from other geographic regions of Europe.
引用
收藏
页码:636 / 639
页数:4
相关论文
共 28 条
  • [21] Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk
    Strautins, K.
    Tschochner, M.
    James, I.
    Choo, L.
    Dunn, D. S.
    Pedrini, M.
    Kermode, A.
    Carroll, W.
    Nolan, D.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (03) : 286 - 294
  • [22] Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome
    Quelvennec, E
    Bera, O
    Cabre, P
    Alizadeh, M
    Smadja, D
    Jugde, F
    Edan, G
    Semana, G
    TISSUE ANTIGENS, 2003, 61 (02): : 166 - 171
  • [23] Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-β 1b-treated multiple sclerosis patients
    Ferrarini, A
    Sivieri, S
    Buttarello, M
    Facchinetti, A
    Perini, P
    Gallo, P
    MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (03) : 174 - 177
  • [24] The HLA-DQ(alpha 1*0102,beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01,beta 1*1501) heterodimer
    Spurkland, A
    Celius, EG
    Knutsen, I
    Beiske, A
    Thorsby, E
    Vartdal, F
    TISSUE ANTIGENS, 1997, 50 (01): : 15 - 22
  • [25] HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the Middle East North Africa region: A systematic review and meta-analysis
    Mohajer, Bahram
    Abbasi, Nooshin
    Pishgar, Farhad
    Abdolalizadeh, Amirhussein
    Ebrahimi, Hedyeh
    Razaviyoun, Taraneh
    Mohebbi, Farnam
    Eskandarieh, Sharareh
    Sahraian, Mohammad Ali
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 321 : 117 - 124
  • [26] Association of HLA-DR2-Related Haplotype (HLA-DRBS*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province
    Delfan, Nooshin
    Galehdari, Hamid
    Mardasi, Farideh Ghanbari
    Zabihi, Rezvan
    Pakdehi, Tahereh Latifi
    Seifi, Tahereh
    Majdinasab, Nastaran
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2021, 15 (03) : 35 - 46
  • [27] CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese
    Rasmussen, HB
    Kelly, MA
    Francis, DA
    Clausen, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) : 143 - 147
  • [28] T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
    Verstegen, Niels J. M.
    Hagen, Ruth R.
    Kreher, Christine
    Kuijper, Lisan H.
    van den Dijssel, Jet
    Ashhurst, Thomas
    Kummer, Laura Y. L.
    Cabeza, Virginia Palomares
    Steenhuis, Maurice
    Duurland, Mariel C.
    de Jongh, Rivka
    van der Schoot, C. Ellen
    Konijn, Veronique A. L.
    Mul, Erik
    Kedzierska, Katherine
    van Dam, Koos P. J.
    Stalman, Eileen W.
    Boekel, Laura
    Wolbink, Gertjan
    Tas, Sander W.
    Killestein, Joep
    Rispens, Theo
    Wieske, Luuk
    Kuijpers, Taco W.
    Eftimov, Filip
    van Kempen, Zoe L. E.
    van Ham, S. Marieke
    ten Brinke, Anja
    van de Sandt, Carolien E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (09) : 855 - 864